Streetbeat News

Earnings

FNWB

First Northwest Bancorp reported a Q3 2024 GAAP EPS of $(0.23), missing the $0.05 estimate by 560%. Sales were $15.799M, missing the $17.300M estimate by 8.68% and down 11.51% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:32 pm

OPRA

Opera's shares surged following the release of its Q3 financial results, which exceeded expectations. The company also raised its revenue guidance for FY24 and Q4.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:32 pm

AYURF

Ayurcann Holdings Corp., a Canadian cannabis company, reported record gross revenue of CA$45.27 million for fiscal year 2024, marking a 100% increase year-over-year. Despite challenges in the competitive cannabis market, Ayurcann expanded its market share with over 70% penetration in dispensaries and a diverse product range. The company also reported a net revenue of CA$25.16 million and an adjusted EBITDA gain of CA$198,213. Ayurcann shares closed flat at $0.054 per share.

Portfolio Pulse from Nina Zdinjak

October 29, 2024 | 1:32 pm

SSTK

Shutterstock shares rose following strong Q3 results and optimistic FY24 guidance. The company will also integrate its GIPHY API into TikTok's messaging platform.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:31 pm

KINS

Kingstone Companies reported Q3 earnings per share of $0.50, significantly beating the estimate of $0.21, marking a 285.19% increase from last year's loss. However, sales of $33.41M missed the $39.40M estimate, though they increased by 19.57% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:30 pm

CROX

Crocs, Inc. (NASDAQ:CROX) shares fell 17.4% after Q3 earnings report. Despite beating EPS and revenue estimates, the company lowered revenue guidance for its HEYDUDE brand, which is taking longer to recover. Crocs brand showed growth, but HEYDUDE's decline impacted overall outlook.

Portfolio Pulse from Nabaparna Bhattacharya

October 29, 2024 | 1:29 pm

WGS

GeneDx shares rose after the company reported better-than-expected Q3 financial results and increased its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:29 pm

UTMD

Utah Medical Products reported a decrease in Q3 earnings per share and sales compared to the same period last year. EPS fell by 5.09% to $1.02, and sales dropped by 19.99% to $10.01 million.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:28 pm

XRX

Xerox Holdings Corp (NASDAQ: XRX) reported a 7.5% decline in Q3 2024 revenue, marking the seventh consecutive quarter of missing expectations. The company also slashed its 2024 outlook, leading to a significant drop in stock price. Equipment sales decreased by 12.2%, and post-sale revenue declined by 6.1%. Despite some progress in operating income and margins, the outlook for revenue and free cash flow was reduced.

Portfolio Pulse from Anusuya Lahiri

October 29, 2024 | 1:24 pm

SOFI

SoFi Technologies reported strong Q3 earnings, beating revenue and EPS estimates, and raised its full-year guidance. Despite initial gains, shares fell 2.77%.

Portfolio Pulse from Adam Eckert

October 29, 2024 | 1:23 pm